Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Chronic Respiratory Diseases"
Deadline for manuscript submissions: closed (31 August 2016).
Interests: infection and immunity; lung cancer; sleep disorders; lung diseases; respiratory tract diseases
Special Issues and Collections in MDPI journals
For many decades there has been a sense of nihilism about chronic respiratory diseases. Treatment options have been both few in number and disappointing in efficacy. We are now in an exciting era, where significant progress has been made in investigation, treatment, and monitoring of a number of chronic respiratory disorders. We now have antifibrotic agents for fibrotic lung disease, new pharmacological and non-pharmacological therapies for chronic obstructive pulmonary disease (COPD), and new therapies for bronchiectasis. In addition to sputum clearance methodologies for bronchiectasis, we now have therapies aimed at reducing sputum production (e.g., macrolides), and therapy that improves sputum clearance (e.g., nebulised hypertonic saline). The concept of personalised medicine is an increasingly important one, in oncology in particular. This concept is becoming increasingly relevant in a number of chronic respiratory diseases. One example of this is the potential use of sputum and serum eosinophil levels in determining the role of inhaled steroids in COPD. This Special Issue will cover many of the advances in chronic respiratory disorders. We still have a long way to go, but the future is clearly brighter.
Prof. David Barnes
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chronic obstructive pulmonary disease
- interstitial lung disease
- idiopathic pulmonary fibrosis
- chronic asthma
- pulmonary hypertension